Skip To Main Content
Skip To Main Content

Dr. Julie A. Johnson the 2013 Sebok Lecturer

Dr. Julie A. Johnson
V. Ravi Chandran Professor of Pharmaceutical Sciences
University of Florida Colleges of Pharmacy and MedicineImage

“Pharmacogenetics in the clinical setting to guide drug therapy decisions – progress and challenges”

Friday, January 18, 1 p.m.  •  Freed Center for the Performing Arts (ONU Recorded Event)                              

Julie A. Johnson, Pharm.D., BCPS, FCCP, FAHA is the V. Ravi Chandran Professor of Pharmaceutical Sciences, Distinguished Professor of Pharmacy (Departments of Pharmacotherapy and Translational Research (primary), and Pharmaceutics) and Medicine; (Department of Medicine, Division of Cardiovascular Medicine) at the University of Florida Colleges of Pharmacy and Medicine. She is also Director, University of Florida Center for Pharmacogenomics and Director of the UF&Shands Personalized Medicine Program. She joined the faculty at the University of Florida in May 1998, and before that spent 9 years on the University of Tennessee College of Pharmacy faculty. She received her B.S. in Pharmacy from the Ohio State University (1985) and her Pharm.D. from the University of Texas at Austin and the University of Texas Health Science Center at San Antonio (1987). She completed a post-doctoral fellowship in cardiovascular pharmacology/ pharmacokinetics at the Ohio State University (1989).

Dr. Johnson’s research focuses on cardiovascular pharmacogenomics. She leads a research group in the NIH-supported Pharmacogenomics Research Network, with a project focused on pharmacogenomics of antihypertensive drugs. She is a leader in the field of cardiovascular pharmacogenomics, with over 150 peer reviewed publications. She is also leading the University of Florida’s effort in clinical translation of pharmacogenomics.

Dr. Johnson served on the Nonprescription Drugs Advisory Committee of the FDA (2000-2004), is currently serving on the XNDA Study Section at NIH (2007-2012), and is a member of a Protocol Review Committee and Data Safety Monitoring Board, for two NHLBI (NIH) networks. She was also a member of the American Heart Association Committee on Scientific Sessions Programming (2009-2011) and was co-chair for the 2009 AHA International Congress on Genetics and Genomics of Cardiovascular Disease. She served as a Regent of the American College of Clinical Pharmacy (2000-2003), and has had numerous other leadership roles in a variety of national organizations. She is on the editorial boards of the journals Clinical Pharmacology and Therapeutics, Pharmacogenetics and Genomics, Journal of the American Heart Association, Psychosomatic Medicine, and Pharmacogenomics, is a scientific editor for Pharmacotherapy.